Ability of human plasma to inhibit prostaglandin F2 alpha in asthma.
Human plasma has been reported to inhibit the conversion of arachidonic acid into prostaglandin (PG) E2 and PGF2 alpha. In the present study the plasma inhibitory activity was determined in three groups (16 each) of plasma obtained from normal healthy volunteers, treated asthmatics and untreated asthmatic patients. The result showed that plasma from all three groups were equally effective in inhibiting the biosynthesis of PGE2. Plasma of normal volunteers and treated asthmatics also inhibited PGF2 alpha biosynthesis. In contrast the plasma obtained from untreated asthmatics was considerably less active in inhibiting the biosynthesis of PGF2 alpha than plasma from the other two groups.
D001249:Asthma / Q000378:metabolism*; D001798:Blood Proteins / Q000502:physiology; D015237:Dinoprost; D015232:Dinoprostone; D006801:Humans; D011448:Prostaglandin Antagonists / Q000097:blood*; D011458:Prostaglandins E / Q000096:biosynthesis; D011460:Prostaglandins F / Q000037:antagonists & inhibitors* / Q000096:biosynthesis
D001798:Blood Proteins; D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D011460:Prostaglandins F; D015237:Dinoprost; D015232:Dinoprostone